GT Biopharma (GTBP) Shares Outstanding (2016 - 2021)
GT Biopharma (GTBP) has disclosed Shares Outstanding for 10 consecutive years, with $30.5 million as the latest value for Q3 2021.
- On a quarterly basis, Shares Outstanding rose 569.05% to $30.5 million in Q3 2021 year-over-year; TTM through Sep 2021 was $30.5 million, a 569.05% increase, with the full-year FY2020 number at $5.2 million, up 212879.59% from a year prior.
- Shares Outstanding was $96000.0 for Q3 2021 at GT Biopharma, down from $3.2 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $5.2 million in Q4 2020 to a low of $2450.0 in Q2 2019.
- A 4-year average of $1.6 million and a median of $96000.0 in 2021 define the central range for Shares Outstanding.
- Peak YoY movement for Shares Outstanding: soared 186016.94% in 2020, then plummeted 96.07% in 2021.
- GT Biopharma's Shares Outstanding stood at $50118.0 in 2017, then surged by 4788.46% to $2.4 million in 2019, then surged by 112.98% to $5.2 million in 2020, then surged by 484.67% to $30.5 million in 2021.
- Per Business Quant, the three most recent readings for GTBP's Shares Outstanding are $30.5 million (Q3 2021), $96230.0 (Q2 2021), and $2.0 million (Q1 2021).